GlassScriptPhysician profile
Nancy A Little
NPI 1679685374
$18,478.44
in general payments reported to CMS, 2019-2025
28 companies · $424 in 2025
The $424 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,662 · 2020: $7,447 · 2021: $421 · 2022: $1,725 · 2023: $452 · 2024: $347 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.96 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14,403.00 | 2019-2022 | |
| Medtronic, INC. | $1,430.57 | 2022-2025 | Interstim |
| Abbvie INC. | $762.67 | 2020-2025 | |
| Coloplast Corp | $252.95 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.82 | 2019 | |
| Boston Scientific Corporation | $195.66 | 2020-2023 | Lithovue |
| Silk Road Medical, INC. | $194.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $187.26 | 2019 | |
| Sumitomo Pharma America, INC. | $149.94 | 2023-2024 | Gemtesa |
| Therapeuticsmd, INC. | $135.05 | 2019 | |
| Rochester Medical Corporation | $85.65 | 2020-2022 | |
| Antares Pharma, INC. | $66.75 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $54.23 | 2019 | |
| Myriad Genetic Laboratories, INC. | $39.56 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $33.64 | 2023 | |
| Astellas Pharma US INC | $31.04 | 2019-2022 | |
| Urogen Pharma, INC. | $26.69 | 2023 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $24.06 | 2021 | |
| Teleflex LLC | $23.16 | 2022 | |
| Laborie Medical Technologies Corp. | $23.14 | 2025 | |
| Ambu INC. | $21.57 | 2025 | |
| Angiodynamics, INC. | $16.73 | 2025 | Nanoknife |
| Agiliti Surgical, INC. | $15.70 | 2019 | |
| Halozyme INC | $15.36 | 2023 | |
| Amniox Medical, INC. | $14.94 | 2019 | |
| Rgh Enterprises LLC | $14.92 | 2019 | |
| Caldera Medical, INC | $14.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.